Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 248

3.

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage.

Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT.

Cancer. 1996 Feb 15;77(4):697-709.

4.

BRCA1 and BRCA2 mutations among Finnish ovarian carcinoma families.

Sarantaus L, Auranen A, Nevanlinna H.

Int J Oncol. 2001 Apr;18(4):831-5.

PMID:
11251181
5.

Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.

Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.

Clin Cancer Res. 2002 Dec;8(12):3776-81.

6.

A population-based study of BRCA1 and BRCA2 mutations in Jewish women with epithelial ovarian cancer.

Lu KH, Cramer DW, Muto MG, Li EY, Niloff J, Mok SC.

Obstet Gynecol. 1999 Jan;93(1):34-7.

PMID:
9916952
7.

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

Gaffney DK, Hemmersmeier J, Holden J, Marshall J, Smith LM, Avizonis V, Tran T, Neuhausen SL.

Int J Radiat Oncol Biol Phys. 2001 Feb 1;49(2):539-46.

PMID:
11173152
8.

Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds.

Casey MJ, Bewtra C, Hoehne LL, Tatpati AD, Lynch HT, Watson P.

Gynecol Oncol. 2000 Sep;78(3 Pt 1):278-87. Review.

PMID:
10985881
9.

Differences between hereditary and sporadic ovarian cancer.

Zweemer RP, Verheijen RH, Menko FH, Gille JJ, van Diest PJ, Coebergh JW, Shaw PA, Jacobs IJ, Kenemans P.

Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):151-3.

PMID:
10206407
10.

Frequency of BRCA1 and BRCA2 mutations in a clinic-based series of breast and ovarian cancer families.

Vaziri SA, Krumroy LM, Rostai M, Casey G.

Hum Mutat. 2001;17(1):74.

PMID:
11139249
11.
12.

Colorectal cancer in hereditary breast cancer kindreds.

Lin KM, Ternent CA, Adams DR, Thorson AG, Blatchford GJ, Christensen MA, Watson P, Lynch HT.

Dis Colon Rectum. 1999 Aug;42(8):1041-5.

PMID:
10458128
13.

Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2.

Ligtenberg MJ, Hogervorst FB, Willems HW, Arts PJ, Brink G, Hageman S, Bosgoed EA, Van der Looij E, Rookus MA, Devilee P, Vos EM, Wigbout G, Struycken PM, Menko FH, Rutgers EJ, Hoefsloot EH, Mariman EC, Brunner HG, Van 't Veer LJ.

Br J Cancer. 1999 Mar;79(9-10):1475-8.

14.

The contribution of germline BRCA1 and BRCA2 mutations to familial ovarian cancer: no evidence for other ovarian cancer-susceptibility genes.

Gayther SA, Russell P, Harrington P, Antoniou AC, Easton DF, Ponder BA.

Am J Hum Genet. 1999 Oct;65(4):1021-9.

15.

BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.

Soegaard M, Kjaer SK, Cox M, Wozniak E, Høgdall E, Høgdall C, Blaakaer J, Jacobs IJ, Gayther SA, Ramus SJ.

Clin Cancer Res. 2008 Jun 15;14(12):3761-7. doi: 10.1158/1078-0432.CCR-07-4806.

16.

Frequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma cases.

Malone KE, Daling JR, Neal C, Suter NM, O'Brien C, Cushing-Haugen K, Jonasdottir TJ, Thompson JD, Ostrander EA.

Cancer. 2000 Mar 15;88(6):1393-402.

PMID:
10717622
17.

Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.

Rutter JL, Smith AM, Dávila MR, Sigurdson AJ, Giusti RM, Pineda MA, Doody MM, Tucker MA, Greene MH, Zhang J, Struewing JP.

Hum Mutat. 2003 Aug;22(2):121-8.

PMID:
12872252
18.

Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.

Johannsson O, Loman N, Möller T, Kristoffersson U, Borg A, Olsson H.

Eur J Cancer. 1999 Aug;35(8):1248-57.

PMID:
10615237
19.

A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.

Machácková E, Foretová L, Navrátilová M, Valík D, Claes K, Messiaen L.

Cas Lek Cesk. 2000 Oct 11;139(20):635-7.

PMID:
11192759
20.

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history.

Tonin PN, Mes-Masson AM, Narod SA, Ghadirian P, Provencher D.

Clin Genet. 1999 May;55(5):318-24.

PMID:
10422801

Supplemental Content

Support Center